ZA964838B - Treatment of Type II diabetes mellitus with amylin agonists. - Google Patents
Treatment of Type II diabetes mellitus with amylin agonists.Info
- Publication number
- ZA964838B ZA964838B ZA9604838A ZA964838A ZA964838B ZA 964838 B ZA964838 B ZA 964838B ZA 9604838 A ZA9604838 A ZA 9604838A ZA 964838 A ZA964838 A ZA 964838A ZA 964838 B ZA964838 B ZA 964838B
- Authority
- ZA
- South Africa
- Prior art keywords
- diabetes mellitus
- type
- treatment
- amylin agonists
- amylin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/483,188 US6143718A (en) | 1995-06-07 | 1995-06-07 | Treatment of Type II diabetes mellutis with amylin agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA964838B true ZA964838B (en) | 1997-02-24 |
Family
ID=23919034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9604838A ZA964838B (en) | 1995-06-07 | 1996-06-07 | Treatment of Type II diabetes mellitus with amylin agonists. |
Country Status (19)
Country | Link |
---|---|
US (2) | US6143718A (ja) |
EP (1) | EP0772451B1 (ja) |
JP (1) | JP4009319B2 (ja) |
AT (1) | ATE228849T1 (ja) |
AU (1) | AU721489B2 (ja) |
BG (1) | BG101230A (ja) |
CA (1) | CA2196999C (ja) |
CZ (1) | CZ289043B6 (ja) |
DE (1) | DE69625157T2 (ja) |
DK (1) | DK0772451T3 (ja) |
ES (1) | ES2187659T3 (ja) |
HU (1) | HUP9700368A3 (ja) |
IN (1) | IN181672B (ja) |
NO (1) | NO970519L (ja) |
PT (1) | PT772451E (ja) |
RU (1) | RU2166958C2 (ja) |
SK (1) | SK18697A3 (ja) |
WO (1) | WO1996040220A1 (ja) |
ZA (1) | ZA964838B (ja) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU222249B1 (hu) * | 1991-03-08 | 2003-05-28 | Amylin Pharmaceuticals Inc. | Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
RU2177331C2 (ru) * | 1993-09-07 | 2001-12-27 | Амилин Фармасьютикалз, Инк. | Способы регулирования моторики желудочно-кишечного тракта |
US6143718A (en) * | 1995-06-07 | 2000-11-07 | Amylin Pharmaceuticals, Inc. | Treatment of Type II diabetes mellutis with amylin agonists |
US7312196B2 (en) | 1997-01-08 | 2007-12-25 | Amylin Pharmaceuticals, Inc. | Formulations for amylin agonist peptides |
US6410511B2 (en) | 1997-01-08 | 2002-06-25 | Amylin Pharmaceuticals, Inc. | Formulations for amylin agonist peptides |
US7101853B2 (en) * | 1997-05-06 | 2006-09-05 | Amylin Pharmaceuticals, Inc. | Method for treating or preventing gastritis using amylin or amylin agonists |
US7910548B2 (en) * | 1997-06-06 | 2011-03-22 | Amylin Pharmaceuticals, Inc. | Methods for treating obesity |
ES2316161T3 (es) * | 1998-01-09 | 2009-04-01 | Amylin Pharmaceuticals, Inc. | Formulaciones para peptidos agonistas de amilina con insulina. |
US6087334A (en) * | 1998-08-21 | 2000-07-11 | Amylin Pharmaceuticals, Inc. | Anti-diabetic peptides |
WO2003057244A2 (en) * | 2002-01-08 | 2003-07-17 | Amylin Pharmaceuticals, Inc. | Use of amylin agonists to modulate triglycerides |
PL374860A1 (en) * | 2002-07-09 | 2005-11-14 | Bristol-Myers Squibb Company | Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
AU2004241242A1 (en) * | 2003-05-14 | 2004-12-02 | Emisphere Technologies, Inc. | Compositions for delivering peptide YY and PYY agonists |
US8501473B2 (en) * | 2003-07-16 | 2013-08-06 | Evotec International Gmbh | Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
US8114958B2 (en) * | 2004-02-11 | 2012-02-14 | Amylin Pharmaceuticals, Inc. | Amylin family peptides |
US20050209148A1 (en) * | 2004-02-20 | 2005-09-22 | Arnon Rosenthal | Methods of treating obesity or diabetes using NT-4/5 |
US7399744B2 (en) * | 2004-03-04 | 2008-07-15 | Amylin Pharmaceuticals, Inc. | Methods for affecting body composition |
AU2006223161B2 (en) * | 2005-03-11 | 2011-05-12 | Endo Pharmaceuticals Solutions Inc. | Controlled release formulations of octreotide |
US7759312B2 (en) * | 2005-03-11 | 2010-07-20 | Endo Pharmaceuticals Solutions Inc. | Delivery of dry formulations of octreotide |
JP2009525319A (ja) * | 2006-02-02 | 2009-07-09 | ライナット ニューロサイエンス コーポレイション | trkBアンタゴニストを投与することにより肥満を治療する方法 |
NL2000464C2 (nl) * | 2006-02-02 | 2007-09-11 | Rinat Neuroscience Corp | Werkwijzen voor het behandelen van ongewenst gewichtsverlies of eetstoornissen door het toedienen van een TRKB-agonist. |
BRPI0720473A2 (pt) * | 2006-12-20 | 2014-01-14 | Rinat Neuroscience Corp | Agonistas de trkb para tratamento de distúbios autoimunes |
MX2010005345A (es) * | 2007-11-14 | 2010-08-31 | Amylin Pharmaceuticals Inc | Metodos para el tratamiento de la obesidad y enfermedades y trastornos relacionados con la obesidad. |
US8071537B2 (en) | 2008-06-25 | 2011-12-06 | Endo Pharmaceuticals Solutions Inc. | Implantable device for the sustained release of a polypeptide |
JP5536053B2 (ja) * | 2008-06-25 | 2014-07-02 | エンド ファーマスーティカルズ ソリューションズ インコーポレイテッド. | 離型剤を有するオクトレオチドインプラント |
RS56632B1 (sr) | 2008-10-17 | 2018-03-30 | Sanofi Aventis Deutschland | Kombinacija insulina i glp-1-agonista |
JP2009149684A (ja) * | 2009-03-11 | 2009-07-09 | Amylin Pharmaceut Inc | アミリン作動薬ペプチド用製剤 |
EP2405934B1 (en) * | 2009-03-12 | 2014-03-26 | Nordic Bioscience A/S | Treatment of diabetes and metabolic syndrome |
AU2010317995B2 (en) | 2009-11-13 | 2014-04-17 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical composition comprising a GLP-1 agonist, an insulin, and methionine |
US20110118178A1 (en) * | 2009-11-13 | 2011-05-19 | Sanofi-Aventis Deutschland Gmbh | Method of treatment of diabetes type 2 comprising add-on therapy to insulin glargine and metformin |
US20110118180A1 (en) * | 2009-11-13 | 2011-05-19 | Sanofi-Aventis Deutschland Gmbh | Method of treatment of diabetes type 2 comprising add-on therapy to metformin |
CN102711804B (zh) | 2009-11-13 | 2015-09-16 | 赛诺菲-安万特德国有限公司 | 包含glp-1激动剂和甲硫氨酸的药物组合物 |
JP6199186B2 (ja) | 2010-08-30 | 2017-09-20 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 2型糖尿病の治療用の医薬の製造のためのave0010の使用 |
US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
JP6367115B2 (ja) | 2011-08-29 | 2018-08-01 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 2型糖尿病患者の血糖コントロールに使用する組合せ医薬 |
TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
BR102013017626A2 (pt) * | 2013-06-14 | 2015-02-10 | Univ Rio De Janeiro | Bioconjugados não aglomerantes de amilinomiméticos com polietilenoglicol, uso de bioconjugados não aglomerantes de amilinomiméticos com polietilenoglicol, composições farmacêuticas de baixa toxicidade, adjuvante para a prevenção ou tratamento das doenças, medicamento, método de tratamento ou prevenção de doenças. |
EP3189071B1 (en) * | 2014-09-04 | 2021-07-28 | Novo Nordisk A/S | Novel amylin and calcitonin receptor agonist |
MX2017007699A (es) | 2014-12-12 | 2017-09-18 | Sanofi Aventis Deutschland | Formulacion de proporcion fija de insulina glargina/lixisenatida. |
TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患治療 |
TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患之治療 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8720115D0 (en) * | 1987-08-26 | 1987-09-30 | Cooper G J S | Treatment of diabetes mellitus |
US5367052A (en) * | 1987-04-27 | 1994-11-22 | Amylin Pharmaceuticals, Inc. | Amylin peptides |
US5266561A (en) * | 1988-01-11 | 1993-11-30 | Amylin Pharmaceuticals, Inc. | Treatment of type 2 diabetes mellitus |
US5175145A (en) * | 1988-08-26 | 1992-12-29 | Amylin Pharmaceuticals, Inc. | Treatment of diabetes mellitus with amylin agonists |
US5264372A (en) * | 1991-03-15 | 1993-11-23 | Amylin Pharmaceuticals, Inc. | Receptor-based screening methods for amylin agonists and antagonists |
US5234906A (en) * | 1991-01-10 | 1993-08-10 | Amylin Pharmaceuticals, Inc. | Hyperglycemic compositions |
US5321008A (en) * | 1991-01-10 | 1994-06-14 | Amylin Pharmaceuticals, Inc. | Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions |
HU222249B1 (hu) * | 1991-03-08 | 2003-05-28 | Amylin Pharmaceuticals Inc. | Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
DK0567626T3 (da) * | 1991-11-19 | 2001-12-17 | Amylin Pharmaceuticals Inc | Amylin-agonist-peptider og anvendelse deraf |
US5376638A (en) * | 1992-09-01 | 1994-12-27 | Amylin Pharmaceuticals, Inc. | Methods for treating renin-related disorders with amylin antagonists |
RU2177331C2 (ru) * | 1993-09-07 | 2001-12-27 | Амилин Фармасьютикалз, Инк. | Способы регулирования моторики желудочно-кишечного тракта |
US6143718A (en) * | 1995-06-07 | 2000-11-07 | Amylin Pharmaceuticals, Inc. | Treatment of Type II diabetes mellutis with amylin agonists |
US6087334A (en) | 1998-08-21 | 2000-07-11 | Amylin Pharmaceuticals, Inc. | Anti-diabetic peptides |
-
1995
- 1995-06-07 US US08/483,188 patent/US6143718A/en not_active Expired - Lifetime
-
1996
- 1996-06-07 PT PT96921467T patent/PT772451E/pt unknown
- 1996-06-07 RU RU97104029/14A patent/RU2166958C2/ru not_active IP Right Cessation
- 1996-06-07 AT AT96921467T patent/ATE228849T1/de active
- 1996-06-07 DK DK96921467T patent/DK0772451T3/da active
- 1996-06-07 HU HU9700368A patent/HUP9700368A3/hu unknown
- 1996-06-07 DE DE69625157T patent/DE69625157T2/de not_active Expired - Lifetime
- 1996-06-07 ES ES96921467T patent/ES2187659T3/es not_active Expired - Lifetime
- 1996-06-07 SK SK186-97A patent/SK18697A3/sk unknown
- 1996-06-07 ZA ZA9604838A patent/ZA964838B/xx unknown
- 1996-06-07 CZ CZ1997337A patent/CZ289043B6/cs not_active IP Right Cessation
- 1996-06-07 EP EP96921467A patent/EP0772451B1/en not_active Expired - Lifetime
- 1996-06-07 JP JP50206197A patent/JP4009319B2/ja not_active Expired - Fee Related
- 1996-06-07 CA CA2196999A patent/CA2196999C/en not_active Expired - Fee Related
- 1996-06-07 AU AU62685/96A patent/AU721489B2/en not_active Ceased
- 1996-06-07 IN IN1053CA1996 patent/IN181672B/en unknown
- 1996-06-07 WO PCT/US1996/009875 patent/WO1996040220A1/en not_active Application Discontinuation
-
1997
- 1997-02-05 NO NO970519A patent/NO970519L/no unknown
- 1997-02-13 BG BG101230A patent/BG101230A/xx unknown
-
2000
- 2000-11-06 US US09/707,370 patent/US6417164B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US6417164B1 (en) | 2002-07-09 |
JP4009319B2 (ja) | 2007-11-14 |
CZ33797A3 (en) | 1997-07-16 |
HU9700368D0 (en) | 1997-04-28 |
DE69625157D1 (de) | 2003-01-16 |
HUP9700368A3 (en) | 2001-03-28 |
RU2166958C2 (ru) | 2001-05-20 |
CA2196999A1 (en) | 1996-12-19 |
NO970519D0 (no) | 1997-02-05 |
CZ289043B6 (cs) | 2001-10-17 |
JPH10503785A (ja) | 1998-04-07 |
WO1996040220A1 (en) | 1996-12-19 |
HUP9700368A2 (hu) | 1998-06-29 |
NO970519L (no) | 1997-04-07 |
BG101230A (en) | 1997-10-31 |
DE69625157T2 (de) | 2003-04-17 |
ATE228849T1 (de) | 2002-12-15 |
US6143718A (en) | 2000-11-07 |
AU6268596A (en) | 1996-12-30 |
EP0772451A4 (en) | 1998-09-30 |
ES2187659T3 (es) | 2003-06-16 |
DK0772451T3 (da) | 2003-01-06 |
EP0772451B1 (en) | 2002-12-04 |
AU721489B2 (en) | 2000-07-06 |
IN181672B (ja) | 1998-08-29 |
CA2196999C (en) | 2012-09-04 |
PT772451E (pt) | 2003-04-30 |
SK18697A3 (en) | 1998-02-04 |
EP0772451A1 (en) | 1997-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA964838B (en) | Treatment of Type II diabetes mellitus with amylin agonists. | |
AU1718400A (en) | Method for treating pain | |
UA29484C2 (uk) | Спосіб лікування міокардиту, кардіоміопатії, ендокардиту і перикардиту | |
EE03202B1 (et) | Intravaginaalne manustussüsteem ja selle valmistamismeetod | |
AU9021298A (en) | Agmatine as a treatment for neuropathic pain | |
SI0804479T1 (sl) | Metoda zdravljenja sladkorne bolezni z uporabo kgf | |
AU7284098A (en) | Method for preventing gastritis using amylin or amylin agonists | |
AU1553388A (en) | Treatment of diabetes | |
FI951511A0 (fi) | IL-10:n käyttö insuliinista riippuvan diabetes mellituksen ennaltaestoon tai hoitoon | |
ZA975867B (en) | Hypoglycemic and hypolipidemic compounds | |
BG104059A (en) | Diabetes treatment with rosiglytazone and insulin | |
AU2196297A (en) | Methods of treating or preventing interstitial cystitis | |
BG104058A (en) | Diabetes treatment with thiazolydindion and sulphonylurea | |
TW330933B (en) | Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes | |
IL126158A0 (en) | Method for treating substance abuse | |
ES8500951A1 (es) | Un procedimiento para preparar 6-metil-tio-espiro-ckroman-4,4' imidazolin-2',5'-diona. | |
ES2141044A1 (es) | Terapia con oxibutinina. | |
MX9700626A (es) | USO DE AZASPIRANOS EN LA REPARACIaN DE COMPOSICIONES PARA TRATAR INFECCIONES OPORTUNISTAS. | |
HU896157D0 (en) | Acupunctural needle, particularly for long-time acupunctural treatment | |
UA19610A (uk) | Спосіб лікуваhhя опісторхозhої іhвазії | |
MX9800365A (es) | Tratamiento de leucemia aguda con interleucina-10. | |
UA15363A (uk) | Засіб для лікуваhhя відкритих пошкоджеhь |